Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study-Reference-Cited by-同舟云学术

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Published:2015-02 Issue:2 Volume:16 Page:187-199
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bradley Jeffrey D,Paulus Rebecca,Komaki Ritsuko,Masters Gregory,Blumenschein George,Schild Steven,Bogart Jeffrey,Hu Chen,Forster Kenneth,Magliocco Anthony,Kavadi Vivek,Garces Yolanda I,Narayan Samir,Iyengar Puneeth,Robinson Cliff,Wynn Raymond B,Koprowski Christopher,Meng Joanne,Beitler Jonathan,Gaur Rakesh,Curran Walter,Choy Hak

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

2. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117;Bradley;Int J Radiat Oncol Biol Phys,2010

3. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117;Bradley;J Clin Oncol,2010

4. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer;Schild;Int J Radiat Oncol Biol Phys,2006

5. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105;Socinski;J Clin Oncol,2008

Cited by 1667 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy;Radiotherapy and Oncology;2024-11

2. Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-11

3. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial;Radiotherapy and Oncology;2024-11

4. Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing;Radiotherapy and Oncology;2024-11

5. Echocardiographic Functional Outcomes Following Regional Nodal Irradiation for Breast Cancer Using Volumetric Modulated Arc Therapy;Advances in Radiation Oncology;2024-10